The novel coronavirus disease COVID-19 that emerged in 2019 is caused by the virus SARS CoV-2 and named for its close genetic similarity to SARS CoV-1 that caused severe acute respiratory syndrome (SARS) in 2002. Both SARS coronavirus genomes encode two overlapping large polyproteins, which are cleaved at specific sites by a 3C-like cysteine protease (3CLpro) in a post-translational processing step that is critical for coronavirus replication. The 3CLpro sequences for CoV-1 and CoV-2 viruses are 100% identical in the catalytic domain that carries out protein cleavage. A research effort that focused on the discovery of reversible and irreversible ketone-based inhibitors of SARS CoV-1 3CLpro employing ligand-protease structures solved by X-ray crystallography led to the identification of 3 and 4. Preclinical experiments reveal 4 (PF-00835231) as a potent inhibitor of CoV-2 3CLpro with suitable pharmaceutical properties to warrant further development as an intravenous treatment for COVID-19.
The novel coronavirus diseasen class="Disease">COVID-19 that emerged in 2019 is caused by the virus SARS CoV-2 and named for its close genetic similarity to SARS CoV-1 that caused severe acute respiratory syndrome (SARS) in 2002. Both SARS coronavirus genomes encode two overlapping large polyproteins, which are cleaved at specific sites by a 3C-like cysteine protease (3CLpro) in a post-translational processing step that is critical for coronavirus replication. The 3CLpro sequences for CoV-1 and CoV-2 viruses are 100% identical in the catalytic domain that carries out protein cleavage. A research effort that focused on the discovery of reversible and irreversible ketone-based inhibitors of SARS CoV-1 3CLpro employing ligand-protease structures solved by X-ray crystallography led to the identification of 3 and 4. Preclinical experiments reveal 4 (PF-00835231) as a potent inhibitor of CoV-23CLpro with suitable pharmaceutical properties to warrant further development as an intravenous treatment for COVID-19.
Authors: A K Patick; S L Binford; M A Brothers; R L Jackson; C E Ford; M D Diem; F Maldonado; P S Dragovich; R Zhou; T J Prins; S A Fuhrman; J W Meador; L S Zalman; D A Matthews; S T Worland Journal: Antimicrob Agents Chemother Date: 1999-10 Impact factor: 5.191
Authors: P S Dragovich; T J Prins; R Zhou; S E Webber; J T Marakovits; S A Fuhrman; A K Patick; D A Matthews; C A Lee; C E Ford; B J Burke; P A Rejto; T F Hendrickson; T Tuntland; E L Brown; J W Meador; R A Ferre; J E Harr; M B Kosa; S T Worland Journal: J Med Chem Date: 1999-04-08 Impact factor: 7.446
Authors: Shu-Hui Chen; Jason Lamar; Frantz Victor; Nancy Snyder; Robert Johnson; Beverly A Heinz; Mark Wakulchik; Q May Wang Journal: Bioorg Med Chem Lett Date: 2003-10-20 Impact factor: 2.823
Authors: S E Webber; K Okano; T L Little; S H Reich; Y Xin; S A Fuhrman; D A Matthews; R A Love; T F Hendrickson; A K Patick; J W Meador; R A Ferre; E L Brown; C E Ford; S L Binford; S T Worland Journal: J Med Chem Date: 1998-07-16 Impact factor: 7.446
Authors: Mark S Cooper; Linlin Zhang; Mohamed Ibrahim; Kaixuan Zhang; Xinyuanyuan Sun; Judith Röske; Matthias Göhl; Mark Brönstrup; Justin K Cowell; Lucie Sauerhering; Stephan Becker; Laura Vangeel; Dirk Jochmans; Johan Neyts; Katharina Rox; Graham P Marsh; Hannah J Maple; Rolf Hilgenfeld Journal: J Med Chem Date: 2022-09-30 Impact factor: 8.039
Authors: Wayne Vuong; Conrad Fischer; Muhammad Bashir Khan; Marco J van Belkum; Tess Lamer; Kurtis D Willoughby; Jimmy Lu; Elena Arutyunova; Michael A Joyce; Holly A Saffran; Justin A Shields; Howard S Young; James A Nieman; D Lorne Tyrrell; M Joanne Lemieux; John C Vederas Journal: Eur J Med Chem Date: 2021-05-30 Impact factor: 7.088
Authors: Jennifer C Milligan; Theresa U Zeisner; George Papageorgiou; Dhira Joshi; Christelle Soudy; Rachel Ulferts; Mary Wu; Chew Theng Lim; Kang Wei Tan; Florian Weissmann; Berta Canal; Ryo Fujisawa; Tom Deegan; Hema Nagaraj; Ganka Bineva-Todd; Clovis Basier; Joseph F Curran; Michael Howell; Rupert Beale; Karim Labib; Nicola O'Reilly; John F X Diffley Journal: Biochem J Date: 2021-07-16 Impact factor: 3.857
Authors: Matthew D Hall; James M Anderson; Annaliesa Anderson; David Baker; Jay Bradner; Kyle R Brimacombe; Elizabeth A Campbell; Kizzmekia S Corbett; Kara Carter; Sara Cherry; Lillian Chiang; Tomas Cihlar; Emmie de Wit; Mark Denison; Matthew Disney; Courtney V Fletcher; Stephanie L Ford-Scheimer; Matthias Götte; Abigail C Grossman; Frederick G Hayden; Daria J Hazuda; Charlotte A Lanteri; Hilary Marston; Andrew D Mesecar; Stephanie Moore; Jennifer O Nwankwo; Jules O'Rear; George Painter; Kumar Singh Saikatendu; Celia A Schiffer; Timothy P Sheahan; Pei-Yong Shi; Hugh D Smyth; Michael J Sofia; Marla Weetall; Sandra K Weller; Richard Whitley; Anthony S Fauci; Christopher P Austin; Francis S Collins; Anthony J Conley; Mindy I Davis Journal: J Infect Dis Date: 2021-07-15 Impact factor: 7.759
Authors: Chamandi S Dampalla; Yunjeong Kim; Naemi Bickmeier; Athri D Rathnayake; Harry Nhat Nguyen; Jian Zheng; Maithri M Kashipathy; Matthew A Baird; Kevin P Battaile; Scott Lovell; Stanley Perlman; Kyeong-Ok Chang; William C Groutas Journal: J Med Chem Date: 2021-07-02 Impact factor: 7.446